Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MiFlaPRO: MPFF for Chronic Radiation Proctitis
NCT04335617Phase 3Unknown
- Sponsor
- Medical University of Innsbruck
- Start
- Feb 2020
- Primary completion
- Feb 2023
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of micronized purified flavonoid fraction in radiation proctitis (2 arms), sponsored by Medical University of Innsbruck. Primary endpoint: Number of necessary interventions at 360 days. Status: unknown.
02
Drugs
micronized purified flavonoid fraction
03
Conditions
radiation proctitis
Beyond the preview
Go deeper on NCT04335617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335617.